Afrodor

Afrodor

Afrodor is a pharmaceutical drug used primarily in the treatment of certain cardiovascular conditions. It is classified as a vasodilator, which means it works by relaxing blood vessels to improve blood flow. This article provides a comprehensive overview of Afrodor, including its mechanism of action, clinical uses, side effects, and related topics.

Mechanism of Action

Afrodor functions by targeting specific receptors in the vascular smooth muscle, leading to vasodilation. This process reduces the resistance in the blood vessels, thereby lowering blood pressure and improving blood flow to various organs. The exact molecular pathways involve the modulation of calcium ion channels and the nitric oxide signaling pathway.

Clinical Uses

Afrodor is primarily prescribed for the following conditions:

• Hypertension: As a vasodilator, Afrodor is effective in lowering high blood pressure, which reduces the risk of stroke, heart attack, and other cardiovascular complications.
• Angina Pectoris: By improving blood flow to the heart muscle, Afrodor helps alleviate the chest pain associated with angina.
• Heart Failure: In some cases, Afrodor is used as part of a combination therapy to manage symptoms of heart failure by reducing the workload on the heart.

Dosage and Administration

Afrodor is available in various forms, including oral tablets and intravenous injections. The dosage depends on the specific condition being treated, the severity of the condition, and the patient's response to the medication. It is crucial to follow the prescribing physician's instructions and not to adjust the dose without medical consultation.

Side Effects

Common side effects of Afrodor include:

• Headache: Due to the vasodilation effect, some patients may experience headaches.
• Dizziness: A drop in blood pressure can lead to dizziness, especially when standing up quickly.
• Flushing: Some patients may experience a warm sensation or redness in the skin.

Serious side effects are rare but can include severe hypotension, allergic reactions, and heart palpitations. Patients should seek immediate medical attention if they experience any severe or concerning symptoms.

Contraindications

Afrodor is contraindicated in patients with:

• Severe hypotension: As it can further lower blood pressure.
• Known hypersensitivity: To any component of the drug.
• Certain heart conditions: Such as severe aortic stenosis.

Drug Interactions

Afrodor can interact with other medications, including:

• Antihypertensives: Concurrent use can lead to an additive effect, increasing the risk of hypotension.
• Nitrates: Can cause severe hypotension when used together.
• Alcohol: May enhance the blood pressure-lowering effect of Afrodor.

Also see

• Vasodilator
• Hypertension
• Angina Pectoris
• Heart Failure
• Calcium Channel Blocker

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy